down arrow

Ainos, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US00902F3038
USD
2.50
0.44 (21.36%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

2.332.56

52 Week

1.785.00
Valuation
Technical
Day's Volume

CASH

67.95 k

Shareholding (Jun 2025)

FII

0.10%

Held by 3 FIIs

DII

99.74%

Held by 0 DIIs

Promoter

0.00%

How big is Ainos, Inc.?

22-Jun-2025

As of Jun 18, Ainos, Inc. has a market capitalization of 11.17 million, with net sales of 0.11 million and a net profit of -14.84 million over the last four quarters. As of Dec 24, the company reported shareholder's funds of 15.52 million and total assets of 28.82 million.

As of Jun 18, Ainos, Inc. has a market capitalization of 11.17 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of Net Sales for the latest four quarters is 0.11 million, while the sum of Net Profit for the same period is -14.84 million.<BR><BR>As of Dec 24, the reporting period shows Shareholder's Funds of 15.52 million and Total Assets of 28.82 million.

Read More

What does Ainos, Inc. do?

22-Jun-2025

Ainos, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $0 million and a net loss of $3 million as of March 2025. It has a market cap of $11.17 million, with key metrics indicating a loss-making status and a debt-to-equity ratio of 0.71.

Overview:<BR>Ainos, Inc. operates in the Pharmaceuticals & Biotechnology industry and is categorized as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 0 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -3 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 11.17 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: 0.71 <BR>Return on Equity: -109.90% <BR>Price to Book: 0.85<BR><BR>Contact Details:<BR>Registrar Address: Not available.

Read More

Is Ainos, Inc. overvalued or undervalued?

25-Jun-2025

As of March 8, 2024, Ainos, Inc. is considered overvalued with poor financial metrics, including negative earnings and high debt, resulting in a significant decline in its valuation outlook compared to peers and an underperformance of -40.17% against the S&P 500.

As of 8 March 2024, Ainos, Inc. has moved from a grade of risky to does not qualify, indicating a significant deterioration in its valuation outlook. The company is currently considered overvalued given its financial metrics, including a Price to Book Value of 1.05 and an EV to Sales ratio of 23.19, which are concerning in the context of its negative earnings and high debt levels. The ROCE stands at -61.73%, and the ROE is alarmingly low at -109.90%, reflecting severe operational inefficiencies.<BR><BR>In comparison to its peers, Ainos, Inc. has a less favorable valuation profile, with Nutriband, Inc. showing a P/E ratio of -14.38 and Nephros, Inc. being classified as attractive with a P/E of 40.07. The stark contrast in performance and valuation metrics suggests that Ainos, Inc. is not only overvalued but also struggling significantly compared to its industry counterparts. Additionally, the company's stock has underperformed the S&P 500 over the past year, with a return of -40.17% compared to the index's 10.26%, further reinforcing the notion of overvaluation.

Read More

Is Ainos, Inc. technically bullish or bearish?

20-Sep-2025

As of September 2, 2025, Ainos, Inc. shows a mildly bullish trend with positive short-term indicators, but a bearish monthly RSI suggests potential long-term weakness, despite outperforming the S&P 500 year-to-date.

As of 2 September 2025, the technical trend for Ainos, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating some positive momentum. The daily moving averages are bullish, supporting a short-term positive outlook. However, the monthly RSI is bearish, which suggests potential weakness in the longer term. The Bollinger Bands are mildly bullish on both weekly and monthly time frames, indicating some upward price movement within a range.<BR><BR>In terms of performance, Ainos, Inc. has outperformed the S&P 500 year-to-date with a return of 53.95% compared to the S&P 500's 12.22%. However, over the longer term, particularly in the 3-year and 5-year periods, the stock has significantly underperformed the benchmark.<BR><BR>Overall, the current technical stance is mildly bullish, driven by the bullish daily moving averages and weekly MACD, but tempered by the bearish monthly RSI.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 17 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.85

stock-summary
Return on Equity

-134.39%

stock-summary
Price to Book

1.50

Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Jun 2025)
Net Profit:
-4 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-33.16%
0%
-33.16%
6 Months
-22.41%
0%
-22.41%
1 Year
14.23%
0%
14.23%
2 Years
-83.33%
0%
-83.33%
3 Years
-86.84%
0%
-86.84%
4 Years
316.67%
0%
316.67%
5 Years
1215.79%
0%
1215.79%

Ainos, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is Ainos, Inc. technically bullish or bearish?

As of 2 September 2025, the technical trend for Ainos, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating some positive momentum. The daily moving averages are bullish, supporting a short-term positive outlook. However, the monthly RSI is bearish, which suggests potential weakness in the longer term. The Bollinger Bands are mildly bullish on both weekly and monthly time frames, indicating some upward price movement within a range. In terms of performance, Ainos, Inc. has outperformed the S&P 500 year-to-date with a return of 53.95% compared to the S&P 500's 12.22%. However, over the longer term, particularly in the 3-year and 5-year periods, the stock has significantly underperformed the benchmark. Overall, the current technical stance is mildly bullish, driven by the bullish daily moving averages and weekly MACD, but tempered ...

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
1.74%
EBIT Growth (5y)
-252.84%
EBIT to Interest (avg)
-9.23
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.71
Sales to Capital Employed (avg)
0.02
Tax Ratio
0.01%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
1.20%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.05
EV to EBIT
-1.67
EV to EBITDA
-1.82
EV to Capital Employed
1.03
EV to Sales
23.19
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-61.73%
ROE (Latest)
-109.90%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 1 Schemes (0.16%)

Foreign Institutions

Held by 3 Foreign Institutions (0.1%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -100.00% vs 0.00% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -24.24% vs 29.79% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.60",
          "val2": "-2.00",
          "chgp": "-30.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-4.10",
          "val2": "-3.30",
          "chgp": "-24.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-803,278.40%",
          "val2": "-29,780.20%",
          "chgp": "-77,349.82%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -100.00% vs -97.14% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -7.97% vs 1.43% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-9.00",
          "val2": "-8.10",
          "chgp": "-11.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.60",
          "val2": "0.10",
          "chgp": "500.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.60",
          "val2": "-0.70",
          "chgp": "14.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-14.90",
          "val2": "-13.80",
          "chgp": "-7.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-667,721.70%",
          "val2": "-105,801.40%",
          "chgp": "-56,192.03%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
0.00
0.10
-100.00%
Operating Profit (PBDIT) excl Other Income
-2.60
-2.00
-30.00%
Interest
0.20
0.20
Exceptional Items
0.00
0.00
Consolidate Net Profit
-4.10
-3.30
-24.24%
Operating Profit Margin (Excl OI)
-803,278.40%
-29,780.20%
-77,349.82%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is -100.00% vs 0.00% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -24.24% vs 29.79% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.10
-100.00%
Operating Profit (PBDIT) excl Other Income
-9.00
-8.10
-11.11%
Interest
0.60
0.10
500.00%
Exceptional Items
-0.60
-0.70
14.29%
Consolidate Net Profit
-14.90
-13.80
-7.97%
Operating Profit Margin (Excl OI)
-667,721.70%
-105,801.40%
-56,192.03%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -100.00% vs -97.14% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -7.97% vs 1.43% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Ainos, Inc. stock-summary
stock-summary
Ainos, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."